logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anna Turkina

national medical research center for hematology
H指数:25
被引数:5,098

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia

2025欧洲白血病网关于慢性粒细胞白血病治疗的建议

Leukemia
IF13.4
2025-07-110
OA
Jane F. Apperley; Dragana Milojkovic; Nicholas C. P. Cross; Henrik Hjorth-Hansen; Andreas Hochhaus; Hagop Kantarjian; Jeffrey H. Lipton; Hemant Malhotra; Dietger Niederwieser; Jerald Radich; Philippe Rousselot; Susanne Saussele; Charles A. Schiffer; Richard Silver; Simona Soverini; Leif Stenke; Anna Turkina; Luis Felipe Casado; Fausto Castagnetti; Francisco Cervantes; Richard E. Clark; Jorge Cortes; Michael Deininger; Timothy P. Hughes; Jeroen Janssen; Qian Jiang; Dong-Wook Kim; Richard A. Larson; Francois X. Mahon; Michael Mauro; Jiri Mayer; Franck E. Nicolini; Fabrizio Pane; Delphine Rea; Johan Richter; Gianantonio Rosti; Giuseppe Saglio; Rüdiger Hehlmann
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL

Asciminib在ASCEMBL研究中经过近4年的随访后，在晚期慢性粒细胞白血病慢性期（CML-CP）中仍优于bosutinib。

Blood Advances
IF7.1
2025-05-090
OAAI
Michael J. Mauro; Yosuke Minami; Andreas Hochhaus; Elza Lomaia; Sergey Voloshin; Anna Turkina; Dong-Wook Kim; Jane F. Apperley; Jorge E. Cortes; Andre Abdo; Laura Maria Fogliatto; Dennis Dong Hwan Kim; Philipp le Coutre; Susanne Saussele; Mario Annunziata; Timothy P. Hughes; Naeem Chaudhri; Lynette Chee; Valentin García-Gutiérrez; Koji Sasaki; Carla Boquimpani; Shruti Kapoor; Noemi Espurz; Vishal Dhamal; Delphine Rea
Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia

vamotinib（PF-114）的I期研究，该药是一种第三代BCR::ABL1酪氨酸激酶抑制剂，用于慢性粒细胞白血病。

ANNALS OF HEMATOLOGY
IF2.4
2025-04-290
OA
Turkina, Anna; Vinogradova, Olga; Lomaia, Elza; Shatokhina, Evgeniya; Shukhov, Oleg; Chelysheva, Ekaterina; Shikhbabaeva, Dzhariyat; Nemchenko, Irina; Petrova, Anna; Bykova, Anastasiya; Siordiya, Nadiya; Shuvaev, Vasily; Mikhailov, Ilya; Novikov, Fedor; Shulgina, Veronika; Hochhaus, Andreas; Ottmann, Oliver; Cortes, Jorge; Gale, Robert Peter; Chilov, Ghermes
Allele-Specific PCR for Detection of Missense Mutations in the Chimeric BCR::ABL1 Gene Causing Failure of Tyrosine Kinase Inhibitor Therapy in CML Patients

用于检测导致慢性粒细胞白血病患者酪氨酸激酶抑制剂治疗失败的嵌合BCR::ABL1基因中错义突变的等位基因特异性PCR

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
IF4.9
2025-04-150
OA
Skripkina, Anastasia; Fevraleva, Irina; Kuzmina, Elena; Biderman, Bella; Stepanova, Elena; Chelysheva, Ekaterina; Turkina, Anna; Sudarikov, Andrey
Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study

Asciminib对伊马替尼的补充在ASC4MORE研究中显示持续的高治疗率和深度分子反应，并延长随访时间

JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2024-12-180
OAAI
Hughes, Timothy P.; Saglio, Giuseppe; Geissler, Jan; Kim, Dong-Wook; Lomaia, Elza; Mayer, Jiri; Turkina, Anna; Kapoor, Shruti; Cardoso, Ana Paula; Nieman, Becki; Quenet, Sara; Cortes, Jorge E.
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry (vol 38, pg 788, 2024)
LEUKEMIA
IF13.4
2024-09-170
OAAI
Chelysheva, Ekaterina; Apperley, Jane; Turkina, Anna; Yassin, Mohamed A.; Rea, Delphine; Nicolini, Franck E.; Barraco, Daniela; Kazakbaeva, Khamida; Saliev, Sukhrob; Abulafia, Adi Shacham; Al-Kindi, Salam; Byrne, Jennifer; Robertson, Harry F.; Cerrano, Marco; Shmakov, Roman; Polushkina, Evgenia; de Fabritiis, Paolo; Trawinska, Malgorzata Monika; Abruzzese, Elisabetta
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
LEUKEMIA
IF13.4
2024-02-238
OAAI
Chelysheva, Ekaterina; Apperley, Jane; Turkina, Anna; Yassin, Mohamed A.; Rea, Delphine; Nicolini, Franck E.; Barraco, Daniela; Kazakbaeva, Khamida; Saliev, Sukhrob; Abulafia, Adi Shacham; Al-Kindi, Salam; Byrne, Jennifer; Robertson, Harry F.; Cerrano, Marco; Shmakov, Roman; Polushkina, Evgenia; de Fabritiis, Paolo; Trawinska, Malgorzata Monika; Abruzzese, Elisabetta
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL

在先前用至少两种酪氨酸激酶抑制剂治疗的慢性粒细胞白血病的慢性期中，Asciminib vs bos sutinib: ASCEMBL的长期随访

LEUKEMIA
IF13.4
2023-01-3064
OAAI
Hochhaus, Andreas; Rea, Delphine; Boquimpani, Carla; Minami, Yosuke; Cortes, Jorge E.; Hughes, Timothy P.; Apperley, Jane F.; Lomaia, Elza; Voloshin, Sergey; Turkina, Anna; Kim, Dong-Wook; Abdo, Andre; Fogliatto, Laura Maria; le Coutre, Philipp; Sasaki, Koji; Kim, Dennis Dong Hwan; Saussele, Susanne; Annunziata, Mario; Chaudhri, Naeem; Chee, Lynette; Garcia-Gutierrez, Valentin; Kapoor, Shruti; Allepuz, Alex; Quenet, Sara; Bedoucha, Veronique; Mauro, Michael J.
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
LEUKEMIA
IF13.4
2020-06-2945
OAAI
Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, Francois; Heibl, Sonja; Hehlmann, Rudiger; Faber, Edgar; Turkina, Anna; Ossenkoppele, Gert; Hoglund, Martin; Zaritskey, Andrey; Griskevicius, Laimonas; Olsson-Stromberg, Ulla; Everaus, Hele; Koskenvesa, Perttu; Labar, Boris; Sacha, Tomasz; Zackova, Daniela; Cervantes, Francisco; Colita, Adriana; Zupan, Irena; Bogdanovic, Andrija; Castagnetti, Fausto; Guilhot, Joelle; Hasford, Joerg; Hochhaus, Andreas; Hoffmann, Verena S.
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

欧洲白血病2020治疗慢性粒细胞白血病的建议

LEUKEMIA
IF13.4
2020-03-03955
OAAI
Hochhaus, A.; Baccarani, M.; Silver, R. T.; Schiffer, C.; Apperley, J. F.; Cervantes, F.; Clark, R. E.; Cortes, J. E.; Deininger, M. W.; Guilhot, F.; Hjorth-Hansen, H.; Hughes, T. P.; Janssen, J. J. W. M.; Kantarjian, H. M.; Kim, D. W.; Larson, R. A.; Lipton, J. H.; Mahon, F. X.; Mayer, J.; Nicolini, F.; Niederwieser, D.; Pane, F.; Radich, J. P.; Rea, D.; Richter, J.; Rosti, G.; Rousselot, P.; Saglio, G.; Saussele, S.; Soverini, S.; Steegmann, J. L.; Turkina, A.; Zaritskey, A.; Hehlmann, R.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2019-09-1420
OAAI
Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Stromberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas; Pfirrmann, Markus
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
ANNALS OF INTERNAL MEDICINE
IF15.2
2018-04-03108
PREAI
Mahon, Francois-Xavier; Boquimpani, Carla; Kim, Dong-Wook; Benyamini, Noam; Clementino, Nelma Cristina D.; Shuvaev, Vasily; Ailawadhi, Sikander; Lipton, Jeffrey Howard; Turkina, Anna G.; De Paz, Raquel; Moiraghi, Beatriz; Nicolini, Franck E.; Dengler, Jolanta; Sacha, Tomasz; Takahashi, Naoto; Fellague-Chebra, Rafik; Acharya, Sandip; Wong, Stephane; Jin, Yu; Hughes, Timothy P.
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
LEUKEMIA
IF13.4
2016-08-2976
PREAI
Hoffmann, V. S.; Baccarani, M.; Hasford, J.; Castagnetti, F.; Di Raimondo, F.; Casado, L. F.; Turkina, A.; Zackova, D.; Ossenkoppele, G.; Zaritskey, A.; Hoglund, M.; Simonsson, B.; Indrak, K.; Sninska, Z.; Sacha, T.; Clark, R.; Bogdanovic, A.; Hellmann, A.; Griskevicius, L.; Schubert-Fritschle, G.; Sertic, D.; Guilhot, J.; Lejniece, S.; Zupan, I.; Burgstaller, S.; Koskenvesa, P.; Everaus, H.; Costeas, P.; Lindoerfer, D.; Rosti, G.; Saussele, S.; Hochhaus, A.; Hehlmann, R.
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
LEUKEMIA
IF13.4
2015-03-18176
OAAI
Hoffmann, V. S.; Baccarani, M.; Hasford, J.; Lindoerfer, D.; Burgstaller, S.; Sertic, D.; Costeas, P.; Mayer, J.; Indrak, K.; Everaus, H.; Koskenvesa, P.; Guilhot, J.; Schubert-Fritschle, G.; Castagnetti, F.; Di Raimondo, F.; Lejniece, S.; Griskevicius, L.; Thielen, N.; Sacha, T.; Hellmann, A.; Turkina, A. G.; Zaritskey, A.; Bogdanovic, A.; Sninska, Z.; Zupan, I.; Steegmann, J-L; Simonsson, B.; Clark, R. E.; Covelli, A.; Guidi, G.; Hehlmann, R.
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2014-04-2893
OAAI
Gambacorti-Passerini, Carlo; Bruemmendorf, Tim H.; Kim, Dong-Wook; Turkina, Anna G.; Masszi, Tamas; Assouline, Sarit; Durrant, Simon; Kantarjian, Hagop M.; Khoury, H. Jean; Zaritskey, Andrey; Shen, Zhi-Xiang; Jin, Jie; Vellenga, Edo; Pasquini, Ricardo; Mathews, Vikram; Cervantes, Francisco; Besson, Nadine; Turnbull, Kathleen; Leip, Eric; Kelly, Virginia; Cortes, Jorge E.
Expanding Nilotinib Access in Clinical Trials (ENACT) An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphi Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase

在临床试验中扩大尼洛替尼的使用范围 (ENACT) 在慢性期伊马替尼耐药或伊马替尼不耐受的Philadelphi染色体阳性慢性粒细胞白血病成年患者中口服尼洛替尼的开放标签，多中心研究

CANCER
IF5.1
2011-07-0555
OAAI
Nicolini, Franck E.; Turkina, Anna; Shen, Zhi-Xiang; Gallagher, Neil; Jootar, Saengsuree; Powell, Bayard L.; De Souza, Carmino; Zheng, Ming; Szczudlo, Tomasz; le Coutre, Philipp

研究方向

暂未获取到该数据
A
Andreas Hochhaus
H 指数:127论文数:1,647被引数:9.0万
J
Jörge E. Cortes
H 指数:179论文数:3,580被引数:14.3万
T
Timothy P. Hughes
H 指数:94论文数:804被引数:5.5万
D
Dong‐Wook Kim
H 指数:62论文数:606被引数:2.0万
J
Jane F. Apperley
H 指数:109论文数:809被引数:5.2万
D
Delphine Réa
H 指数:60论文数:417被引数:1.9万
S
Susanne Saußele
H 指数:52论文数:346被引数:1.4万
T
Tomasz Sacha
H 指数:23论文数:227被引数:2,827
M
Michele Baccarani
H 指数:109论文数:1,436被引数:6.2万
R
Richard E. Clark
H 指数:95论文数:826被引数:5.1万